Sort   by:  
 Page size 
UnknownGenetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.
Not available
S-EPMC3396469 | biostudies-literature
UnknownSmoking cessation counseling in vascular surgical practice using the results of interviews and focus groups in the Vascular Surgeon offer and report smoking cessation pilot trial.
Not available
S-EPMC5101996 | biostudies-literature
UnknownSELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.
Not available
S-EPMC6524649 | biostudies-literature
UnknownErlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.
Not available
S-EPMC5154681 | biostudies-literature
UnknownArteriovenous Fistula Maturation, Functional Patency, and Intervention Rates.
Not available
S-EPMC8459303 | biostudies-literature
UnknownIdentification of potential therapeutic targets in prostate cancer through a cross-species approach.
Not available
S-EPMC5840539 | biostudies-literature
UnknownLarge-scale transcriptome-wide association study identifies new prostate cancer risk regions.
Not available
S-EPMC6172280 | biostudies-literature
UnknownImproved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.
Not available
S-EPMC12403244 | biostudies-literature
UnknownPubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.
Not available
S-EPMC4820939 | biostudies-literature
UnknownAssessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.
Not available
S-EPMC4957617 | biostudies-literature
Sort   by:  
 Page size